CompletedNot Applicable

ICBT for Psychological Symptoms Related to the COVID-19 Pandemic Remaining After Societal Opening

Sweden24 participantsStarted 2023-02-01

Plain-language summary

This study aim to investigate the effects of internet-based cognitive behavioral therapy (ICBT) addressing psychological symptoms related to the COVID-19 pandemic and its consequences that remain after societal opening. The target group is adults (18 years or older) who still experience psychological symptoms related to the pandemic and the ICBT consists of eight modules during eight week with weekly support by a therapist. ICBT will be compared to a wait-list control condition. Participants will be recruited in Sweden with nationwide recruitment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Experience mental health problems related to the COVID-19 pandemic and/or its consecuences, which are still experienced as a problem (when the pandemic is not considered as dangerous to the society) * 18 years or older * Adequate ability to speak, read and write in Swedish * Having access to the internet and a smartphone, computer or other device Exclusion Criteria: * Severe psychiatric or somatic issues that makes participation harder or impossible (which can include the diagnosis postcovid) * Ongoing addiction * Acute suicidality * Other ongoing psychological treatment * Recent (within the past 3 months) changes in the dose of psychotropic medication or planned change during the treatment weeks

What they're measuring

Becks Depression Inventory-II

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.

Generalized Anxiety Disorder-7

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.

Trial details

NCT IDNCT05656430

SponsorLinkoeping University

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Depression Symptoms trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Becks Depression Inventory-II

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.

Generalized Anxiety Disorder-7

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.